Loading...

212 posters, 10 topics, 5 sessions, 754 authors, 237 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

The AAPS 101st Annual Meeting

29 April – 2 May, 2023 | Chicago, IL

The AAPS 101st Annual Meeting banner

D36

Patient Demographics, Tumor Characteristics And Outcomes Following Surgical Treatment Of Benign And Malignant Brachial Plexus Tumors: A Systematic Review

Part of Topic

Hand/Extremity

Patient Demographics, Tumor Characteristics and Outcomes following Surgical Treatment of Benign and Malignant Brachial PlexusTumors: A Systematic Review

Introduction

Primarybrachialplexus(BP)tumorsarerare,challenging-to treatentitiesthatmainlyoriginatefromtheneuroectodermalcells.Theseconstitutenearly5%ofallupperextremitytumors,causingpainanddisabilityinaffectedpatients.ClinicalpresentationofBPtumorscandifferdependingontheirlocationandsize.Mostoftentheypresentwithapainfulpalpablemasswithorwithoutneurologicdeficits.ThisisthemostcommonsymptomofpatientswithBPtumors.Asthetumorprogresses,painfulparesthesiaatthedistributionoftheaffectednerveoccurs.Ultimately,progressivelossofmotorfunctionmayoccur.Varioustreatmentoptionshavebeenintroducedforthemanagementofprimarytumorsofthebrachialplexus(BP),rangingfromconservativetherapytowidelocalexcisionwith/withoutpostoperativechemoradiotherapy.However,thereisadiscrepancyabouttheoptimaltreatmentstrategiesforbenignandmalignantlesionsbasedonpathologiccharacteristicsandthelocationoftheBPtumors.Also,noconsensushasbeenestablishedtodescribetheoptimaloperativeapproachfortumorsofthebrachialplexus.Hence,thissystematicreviewwasperformedtoevaluatetheoptimalsurgicalinterventionsaccordingtothepathologiccharacteristicsofthetumoranddescribeoverallpatientoutcomes,survivalrates,andpossibleprognosticfactors

 


The AAPS 101st Annual Meeting » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.